BAYLOR COLLEGE OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 43
- Registration Number
- NCT04157127
- Locations
- 🇺🇸
Baylor College of Medicine Medical Center - McNair Campus, Houston, Texas, United States
🇺🇸Baylor St. Lukes Medical Center, Houston, Texas, United States
🇺🇸Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States
Causal Mechanisms in Adolescent Arterial Stiffness
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 90
- Registration Number
- NCT04128969
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 87
- Registration Number
- NCT04111874
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
- First Posted Date
- 2019-09-23
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 37
- Registration Number
- NCT04099797
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2019-09-18
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT04093648
Feasibility Study of Family Teamwork Peer-Delivery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT04053504
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Advancing Nutritional Science for Children With Functional Dyspepsia
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT04053049
- Locations
- 🇺🇸
Children's Nutrition Research Center, Houston, Texas, United States
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 47
- Registration Number
- NCT04013802
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Texas Children's Hospital, Houston, Texas, United States
Neural and Behavioral Sequelae of Blast-Related Traumatic Brain Injury
Completed
- Conditions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT04012463
Baylor Infant Biomarker of Nutrition Study
Terminated
- Conditions
- First Posted Date
- 2019-06-24
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 21
- Registration Number
- NCT03996395
- Locations
- 🇺🇸
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath